Selecting neuromuscular-blocking drugs for elderly patients

Drugs and Aging

Volumn 20, Issue 2, 2003, Pages 125-140

  Cope, Tristan M ^a   Hunter, Jennifer M ^b,c  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c School of Anaesthesia   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; BENZYLISOQUINOLINE DERIVATIVE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; CISATRACURIUM; DIMETHYLTUBOCURARINE CHLORIDE; DOXACURIUM; MIVACURIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; NEUROMUSCULAR DEPOLARIZING AGENT; PANCURONIUM BROMIDE; PIPECURONIUM BROMIDE; PYRIDOSTIGMINE; RAPACURONIUM BROMIDE; ROCURONIUM; STEROID; SUXAMETHONIUM; TUBOCURARINE CHLORIDE; VECURONIUM;

AGED; AGING; BODY FAT; CRITICAL ILLNESS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG SAFETY; DRUG SENSITIVITY; ENZYME ACTIVITY; HEART OUTPUT; HEMODYNAMICS; HISTAMINE RELEASE; HUMAN; ISOMER; KIDNEY FUNCTION; LIVER FUNCTION; MUSCLE MASS; NEUROMUSCULAR SYNAPSE; PATIENT MONITORING; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW;

AGED; AGING; ANESTHESIA; CHOLINESTERASE INHIBITORS; CRITICAL ILLNESS; HUMANS; NEUROMUSCULAR BLOCKING AGENTS; SURGICAL PROCEDURES, OPERATIVE;

EID: 0037287577     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200320020-00004     Document Type: Review

References (83)

1. Viby-Mogensen J, Ostergaard D, Donati F, et at. Pharmacokinetic studies of neuromuscular blocking agents: good clinical research practice (GCRP). Acta Anaesthesiol Scand 2000; 44: 1169-90
2. Marshall CA. Influence of co-existing disease on anaesthetic management. In: Aitkenhead AR, Jones RM, editors. Clinical anaesthesia. Edinburgh: Churchill Livingstone, 1996: 31-77
3. Evers BM, Townsend Jr CM, Thompson JC. Organ physiology of aging. Surg Clin North Am 1994; 74: 23-39
4. Gariepy LP, Varin F, Donati F, et al. Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium. Clin Pharmacol Ther 1993; 53: 340-7
5. Ornstein E, Lien CA, Matteo RS, et al. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Anesthesiology 1996; 84: 520-5
6. Parker CJ, Hunter JM, Snowdon SL. Effect of age, sex and anaesthetic technique on the pharmacodynamics of atracurium. Br J Anaesth 1993; 70: 38-41
7. Wahba WM. The influence of aging on lung function: clinical significance of changes from age twenty. Anesth Analg 1983; 62: 764-76
8. Berg H, Viby-Mogensen J, Roed J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications: a prospective, randomised and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-103
9. Matteo RS, Brotherton WP. Pharmacokinetics and pharmacodynamics of d-tubocurarine and metocurine in the elderly. Anesth Analg 1985; 64: 23-9
10. Lien CA, Matteo RS, Ornstein E, et al. Distribution, elimination, and action of vecuronium in the elderly. Anesth Analg 1991; 73: 39-42
11. Kent AP, Parker CJ, Hunter JM. Pharmacokinetics of atracurium and laudanosine in the elderly. Br J Anaesth 1989; 63: 661-6
12. Fisher DM, Canfell PC, Fahey MR, et al. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 1986; 65: 6-12
13. Slavov V, Khalil M, Merle JC, et al. Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients. Br J Anaesth 1994; 73: 608-12
14. Kisor DF, Schmith VD, Wargin WA, et al. Importance of the organ-independent elimination of cisatracurium. Anesth Analg 1996; 83: 1065-71
15. Cook DR, Stiller RL. Weakly JN, et al. In vitro metabolism of mivacurium chloride (BW B 1090U) and succinylcholine. Anesth Analg 1989; 68: 452-6
16. Maddineni VR, Mirakhur RK, McCoy EP, et al. Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. Br J Anaesth 1994; 73: 608-12
17. Cook DR, Freeman JA, Lai AA. et al. Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and those with hepatic or renal failure. Anesth Analg 1991; 72: 145 -50
18. Dresner DL, Basta SJ, Ali HH, et al. Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia. Anesth Analg 1990; 71: 498-502
19. Matteo RS, Lieberman IG, Salanitre E, et al. Distribution, elimination and action of d-tubocurarine in neonates, infants, children and adults. Anesth Analg 1984; 63: 799-804
20. Meijer DK, Weitering JG, Scaf AH. Comparative pharmacokinetics of d-tubocurarine and metocurine in man. Anesthesiology 1979; 51: 402-7
21. Upton RA, Nguyen TL, Miller RD, et al. Renal and biliary elimination of vecuronium (ORG NC 45) and pancuronium in rats. Anesth Analg 1982; 61: 313-6
22. Duvaldestin P, Saada J, Berger JL, et al. Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology 1982; 56: 36-40
23. Bencini AF, Scaf AHJ, De Wit APM, et al. Disposition of vecuronium bromide in the cat. Br J Anaesth 1985; 57: 782-8
24. McCarthy G, Elliot P, Mirakhur RK, et al. Onset and duration of action of vecuronium in the elderly: comparison with adults. Acta Anaesthesiol Scand 1992; 36: 383-6
25. Wierda JM, Szenohradszky J, de Wit AP, et al. The pharmacokinetics, urinary and biliary excretion of pipecuronium bromide. Eur J Anaesthesiol 1991; 8: 451-7
26. Ornstein E, Matteo RS, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of pipecuronium bromide (Arduan) in elderly surgical patients. Anesth Analg 1992; 74: 841-4
27. Khuenl-Brady K, Castagnoli KP, Canfell PC, et al. The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat. Anesthesiology 1990; 72: 669-74
28. Matteo RS, Ornstein E, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg 1993; 77: 1193-7
29. van den Broek L, Wierda JM, Smeulers NJ, et al. Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics. J Clin Anesth 1994; 6: 288-96
30. Bevan DR, Fiset P, Balendran P, et al. Pharmacodynamic behaviour of rocuronium in the elderly. Can J Anaesth 1993; 40: 127-32
31. Szenohradsky J, Caldwell JE, Wright PM, et al. Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide. Anesthesiology 1999; 90: 24-35
32. Kahwaji R, Bevan DR, Bikhazi G, et al. Dose-ranging study in younger adults and elderly patients of ORG 9487, a new, rapid onset, short-duration muscle relaxant. Anesth Analg 1997; 84: 1011-8
33. Schiere S, Proost JH, Schuringa M, et al. Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488). Anesth Analg 1999; 88: 640-7
34. Verbeeck RK, Cardinal J, Wallace SM. Effect of age and sex on the plasma binding of acidic and basic drugs. Eur J Clin Pharmacol 1984; 27: 91-7
35. Veering BT, Burm AG, Souverijn JH, et al. The effect of age on serum concentration of albumin and alpha 1-acid glycoprotein. Br J Clin Pharmacol 1990; 29: 201-6
36. Salive ME, Cornoni-Huntley J, Phillips CL, et al. Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol 1992; 45: 213-21
37. Cameron M, Donati F, Varin F. In vitro plasma protein binding of neuromuscular blocking agents in different subpopulations of patients. Anesth Analg 1995; 81: 1019-25
38. Duvaldestin P, Henzel D. Binding of tubocurarine, fazadinium, pancuronium and Org NC45 to serum proteins in normal man and in patients with cirrhosis. Br J Anaesth 1982; 54: 513-6
39. Wood M, Stone WJ, Wood AJJ. Plasma binding of pancuronium: effects of age, sex and disease. Anesth Analg 1983; 62: 29-32
40. Ghonheim MM, Kramer E, Bannow R, et al. Binding of d-tubocurarine to plasma proteins in normal man and in patients with hepatic or renal disease. Anesthesiology 1973; 39: 410-5
41. Lynam DP, Cronnelly R, Castagnoli KP, et al. The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure. Anesthesiology 1988; 69: 227-31
42. Meistelman C, Lienhart A, Leveque C, et al. Pharmacology of vecuronium in patients with end-stage renal failure. Eur J Anaesthesiol 1986; 3: 153-8
43. Bevan DR, Donati F, Gyasi H, et al. Vecuronium in renal failure. Can J Anaesth 1984; 31: 491-6
44. Beauvoir C, Peray P, Daures JP, et al. Pharmacodynamics of vecuronium in patients with and without renal failure: a meta-analysis. Can J Anaesth 1993; 40: 696-702
45. Lepage JY, Malinge M, Cozian A, et al. Vecuronium and atracurium in patients with end-stage renal failure: a comparative study. Br J Anaesth 1987; 59: 1004-10
46. Lebrault C, Duvaldestin P, Henzel D, et al. Pharmacokinetics and pharmacodynamics of vecuronium in patients with cholestasis. Br J Anaesth 1986; 58: 983-7
47. Bencini AF, Scaf AH, Sohn YJ, et al. Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 1986; 58: 988-95
48. Lukin CL, Hein HA, Swygert TH, et al. Duration of vecuronium-induced neuromuscular block as a predictor of liver allograft dysfunction. Anesth Analg 1995; 80: 526-33
49. Kitts JB, Fisher DM, Canfell PC, et al. Pharmacokinetics and pharmacodynamics of atracurium in the elderly. Anesthesiology 1990; 72: 272-5
50. Sorooshian SS, Stafford MA, Eastwood NB, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. Anesthesiology 1996; 84: 1083-91
51. Cook DR, Freeman JA, Lai AA, et al. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 1992; 69: 580-5
52. Rupp SM, Castagnoli KP, Fisher DM, et al. Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults. Anesthesiology 1987; 67: 45-9
53. Fisher DM, Kahwaji R, Bevan D, et al. Factors effecting the pharmacokinetic characteristics of rapacuronium. Anesthesiology 1999; 90: 993-1000
54. Bell PF, Mirakhur RK. Clarke RS. Dose-response studies of atracurium, vecuronium and pancuronium in the elderly. Anaesthesia 1989; 44: 925-7
55. Kurtz A, Plattner O, Sessler DI, et al. The threshold for thermoregulatory vasoconstriction during nitrous oxide/isoflurane anesthesia is lower in the elderly than in young patients. Anesthesiology 1993; 79: 465-9
56. Diefenbach C, Abel M, Buzello W. Greater neuromuscular blocking potency of atracurium during hypothermic than during normothermic cardiopulmonary bypass. Anesth Analg 1992; 75: 675-8
57. Buzello W, Schluermann D, Pollmaecher T, et al. Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium and vecuronium. Anesthesiology 1987; 66: 842-6
58. Buzello W, Schluermann D, Spillner G. Hypothermic cardiopulmonary bypass and neuromuscular blockade by pancuronium and vecuronium. Anesthesiology 1985; 62: 201-4
59. Heier T, Caldwell JE, Sessler DI, et al. Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide: isoflurane anesthesia in humans. Anesthesiology 1991; 74: 815-9
60. Maddineni VR, Mirakhur RK, McCoy EP. Plasma cholinesterase activity in elderly and young adults [letter]. Br J Anaesth 1994; 72: 497
61. Viby-Mogensen J. Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme. Anesthesiology 1980; 53: 517-20
62. Parker CJ, Hunter JM, Snowdon SL. Effect of age, sex and anaesthetic technique on the pharmacokinetics of atracurium. Br J Anaesth 1992; 69: 439-43
63. Shorten GD, Goudsouzian NG, Ali HH. Histamine release following atracurium in the elderly. Anaesthesia 1993; 48: 568-71
64. Mellinghoff H, Radbruch L, Diefenbach C, et al. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion. Anesth Analg 1996; 83: 1072-5
65. Welch RM, Brown A, Ravitch J, et al. The in vitro degradation of cisatracurium, the R, cis-R′-isomer of atracurium, in human and rat plasma. Clin Pharmacol Ther 1995; 58: 132-42
66. Doenicke AW, Czeslick E, Moss J, et al. Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration. Anesth Analg 1998; 87: 434-8
67. Doenicke AW, Soukup J, Hoernecke R, et al. Lack of histamine release with cisatracurium: a double-blind comparison with vecuronium. Anesth Analg 1997; 84: 623-8
68. Devlin JC, Head-Rapson AG, Parker CJ, et al. Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis. Br J Anaesth 1993; 71: 227-31
69. Ostergaard D, Jensen FS, Skovgaard LT, et al. Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity. Acta Anaesthesiol Scand 1995; 39: 1016-8
70. Goudsouzian NG, d'Hollander AA, Viby-Mogensen J. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993; 77: 183-5
71. Dahaba AA, Rehak PH, List WF. A comparison of mivacurium infusion requirements between young and elderly adult patients. Eur J Anaesthesiol 1996; 13: 43-8
72. Goudsouzian N, Nishan MD, Chakravorti S, et al. Prolonged mivacurium infusion in young and elderly adults. Can J Anaesth 1997; 44: 955-62
73. Whittaker M. Plasma cholinesterase variants and the anaesthetist. Anaesthesia 1980; 35: 174-97
74. Montamed C, Donati F, Intubating conditions and blockade after mivacurium, rocuronium and their combination in young and elderly adults. Can J Anaesth 2000; 47: 225-31
75. Martlew RA, Harper NJ. The clinical pharmacology of doxacurium in young adults and in elderly patients. Anaesthesia 1995; 50: 779-82
76. De Mey JC, Rolly G, Den Blauwen N. Doxacurium block is not influenced by age. J Clin Anesth 1995; 7: 453-6
77. McLeod K, Hull CJ, Watson MJ. Effects of ageing on the pharmacokinetics of pancuronium. Br J Anaesth 1979; 51: 435-8
78. Shorten GD, Uppington J, Comunale ME. Changes in plasma catecholamine concentrations and haemodynamic effects of rocuronium and vecuronium in elderly patients. Eur J Anaesthesiol 1998; 15: 335-41
79. Fisher DM, Dempsey GA, Atherton PL, et al. Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by bolus followed by infusion. Anesthesiology 2000; 93; 1384-91
80. Marsh RH, Chmielewski AT, Goat VA. Recovery from pancuronium: a comparison between young and old patients. Anaesthesia 1980; 35: 1193-6
81. Young WL, Backus W, Matteo RS, et al. Pharmacokinetics and pharmacodynamics of neostigmine in the elderly [abstract]. Anesthesiology 1984; 61: 3A
82. Young WL, Matteo RS, Ornstein E. Duration of action of neostigmine and pyridostigmine in the elderly. Anesth Analg 1988; 67: 775-8
83. Vandenbrom RH, Wierda JM, Pancuronium bromide in the intensive care unit: a case of overdose. Anesthesiology 1988; 69: 996-7